Home > Healthcare > Medical Devices > Diagnostic Devices > Pyrogen Testing Market

Pyrogen Testing Market Share

  • Report ID: GMI8867
  • Published Date: Apr 2024
  • Report Format: PDF

Pyrogen Testing Market Share

The pyrogen testing services industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.
 

Pyrogen Testing Market Companies

Some of the eminent market participants operating in the industry include:

  • Almac Group
  • bioMérieux SA
  • Charles River Laboratories International, Inc.      
  • Eurofins Scientific    
  • Fujifilm Holdings Corporation        
  • GenScript Biotech Corporation       
  • Lonza 
  • Merck KGaA  
  • STERIS plc    
  • Thermo Fisher Scientific Inc.
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size for pyrogen testing was valued at USD 1.3 billion in 2023 and is estimated to reach over USD 2.8 billion by 2032, attributed to increasing prevalence of chronic disease diseases, including cardiovascular diseases, diabetes, and cancer.

The LAL test segment in the pyrogen testing market accounted for USD 580.2 million in 2023, as this test provides rapid results with most assays yielding quantitative data within a few hours.

North America market size was USD 530.3 million in 2023, as state-of-the-art facilities and equipment enable accurate, reliable, and efficient detection of pyrogens in pharmaceutical products.

Almac Group, bioM

Pyrogen Testing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 226
  • Countries covered: 22
  • Pages: 190
 Download Free Sample